In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody.
about
Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complexFunctional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytesThe complement receptor 3, CR3 (CD11b/CD18), on T lymphocytes: activation-dependent up-regulation and regulatory functionUncoupling CD21 and CD19 of the B-cell coreceptorBeneficial immunomodulation by Streptococcus mutans anti-P1 monoclonal antibodies is Fc independent and correlates with increased exposure of a relevant target epitopeV1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.The role of complement in the acquired immune response.Requirement for complement in antibody responses is not explained by the classic pathway activator IgM.Complement and viral pathogenesisComplement receptors 1 and 2 in murine antibody responses to IgM-complexed and uncomplexed sheep erythrocytesIgE-mediated enhancement of antibody responses: the beneficial function of IgE?Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies.A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.B-cell extrinsic CR1/CR2 promotes natural antibody production and tolerance induction of anti-alphaGAL-producing B-1 cellsStructural differences between the two human complement C4 isotypes affect the humoral immune response.Antibody response to a T-dependent antigen requires B cell expression of complement receptorsGerminal center initiation, variable gene region hypermutation, and mutant B cell selection without detectable immune complexes on follicular dendritic cells.Protective T cell-independent antiviral antibody responses are dependent on complement.Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon gamma: a possible initiating role of B cells.T cell-dependent immune response in C1q-deficient mice: defective interferon gamma production by antigen-specific T cellsSpecific IgM and Regulation of Antibody Responses.T cell-independent and T cell-dependent immunoglobulin G responses to polyomavirus infection are impaired in complement receptor 2-deficient mice.Humoral response to herpes simplex virus is complement-dependent.Antibody-mediated regulation of the immune response.Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21).Anti-inflammatory and immunosuppressive effects of recombinant soluble complement receptors.Deficiency of decay-accelerating factor and complement receptor 1-related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIgAntiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19.Adherence of Legionella pneumophila to guinea pig peritoneal macrophages, J774 mouse macrophages, and undifferentiated U937 human monocytes: role of Fc and complement receptors.Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b.Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake.Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2Fluorosomes: fluorescent virus-like nanoparticles that represent a convenient tool to visualize receptor-ligand interactions.Detachment of human immunodeficiency virus type 1 from germinal centers by blocking complement receptor type 2.Modeling the presentation of C3d-coated antigen by B lymphocytes: enhancement by CR1/2-BCR co-ligation is selective for the co-ligating antigen.Signal transduction pathways involved in B-cell induction.Follicular dendritic cells specifically express the long CR2/CD21 isoform.Role of Epstein-Barr virus and soluble CD21 in persistent polyclonal B-cell lymphocytosis.Follicular dendritic cells and presentation of antigen and costimulatory signals to B cells.Increased B cell deletion and significantly reduced auto-antibody titre due to premature expression of human complement receptor 2 (CR2, CD21).
P2860
Q24675919-1AD62162-0323-4930-ADFD-B3496FF2FAEAQ24680369-57607E3A-0D89-4DBF-A1AD-3DE7CE92E929Q28211936-7081713B-7B16-4FCE-806C-92D61609A5CBQ30489801-D8EB8A95-DE48-4136-B8EB-7EC6EB34BE28Q33607518-75BE7975-03C1-43D3-BDB1-E666A3EAC18EQ33874253-44C14A31-8736-429C-86C3-523D1FF0CB2AQ33917858-3740A228-77D1-4A3C-9225-5936C1CFF39BQ34046071-84A77D55-E6EF-40D9-8544-7B4EBC288B54Q34162421-10DCDFCC-C7A1-44F1-AB0F-F01997602468Q34359343-3F9186F0-2711-4035-9AEA-F8F9580192E8Q34722781-2E0C2618-68C9-4CA7-B6A7-5E8C27E3EFDEQ34999724-4D8DA332-8480-4EDE-AC20-FE12EFAF8874Q35002158-DB20241D-0085-456E-931A-7BF04E6991CDQ35628964-29F0F534-429E-4882-95AB-30332D2AC01FQ36230964-1633B296-75C8-4C48-B6D9-481B12E459AAQ36366376-387B2E73-7C38-4E3D-8944-34854E8EF824Q36368941-62C6040F-D06B-4542-8491-4DA6A46C0BCBQ36375462-16A595F5-14B7-45CC-BA0E-CC80F912C326Q36380633-AB5B1FB1-614C-4D45-AA7E-FC3BFA797AF8Q36400924-73B05108-7F71-4EDB-BFDE-442B6F297E17Q36413052-C412EB1B-0A76-42E3-9C71-B7AFA82C81FAQ36467689-AC0AC493-7306-4295-91FC-DB324AECB040Q36552488-5E6CF3E3-32F2-44FC-BDAB-D25CE4CC8A67Q36570643-E10AD07C-3BB3-4B27-BB25-33649CF7F956Q36645449-9849F6FA-F145-48EF-9076-18CDC6854132Q36691265-1576F043-B61C-4917-93E0-4A7F9C1914C5Q36835163-597758CA-7A06-42F4-8353-8A4061D56488Q36851746-3CD77615-DC4F-49E6-9B2F-82E30178584CQ36972878-DC387CF0-24FF-4AF6-857F-9438DE1997B8Q37348541-831FEACD-F278-483E-A616-23EC41F23262Q37577978-2C7F01FC-C5A0-46B1-A673-DB248F4BEFB8Q37652278-39082565-FF4E-4252-898A-D4E320FC2DA3Q38123692-5E8FAD12-2B71-4EE9-9425-B524F88BAD32Q39593041-8E265BE1-731E-4F6D-A374-2837E53D8880Q40748022-564AC9F1-DB0F-4C74-929D-1D2118BAE9EFQ40833877-0B728127-A234-4477-84B6-2F022DE46D40Q41135074-217A3B48-2826-440B-A332-310A2DBB7283Q41329469-20D5BD2C-E849-45D7-98D7-92339FB4BF1EQ41492202-2A79E45A-164E-458E-9673-EE74490EC128Q41780931-DC2595FA-C45C-48FF-8F15-9EE5730B116E
P2860
In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
In vivo inhibition of the anti ...... -specific monoclonal antibody.
@ast
In vivo inhibition of the anti ...... -specific monoclonal antibody.
@en
type
label
In vivo inhibition of the anti ...... -specific monoclonal antibody.
@ast
In vivo inhibition of the anti ...... -specific monoclonal antibody.
@en
prefLabel
In vivo inhibition of the anti ...... -specific monoclonal antibody.
@ast
In vivo inhibition of the anti ...... -specific monoclonal antibody.
@en
P2860
P356
P1476
In vivo inhibition of the anti ...... r-specific monoclonal antibody
@en
P2093
E J Wiersma
T Kinoshita
P2860
P304
P356
10.1084/JEM.172.2.665
P407
P577
1990-08-01T00:00:00Z